CLINICAL PHARMACOKINETICS OF DISOPYRAMIDE

被引：35

作者：

KARIM, A

NISSEN, C

AZARNOFF, DL

机构：

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1982年 / 10卷 / 05期

关键词：

D O I：

10.1007/BF01059032

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：465 / 494

页数：30

共 76 条

[1] PLASMA-CONCENTRATIONS AND PROTEIN-BINDING OF DISOPYRAMIDE AND MONO-N-DEALKYLDISOPYRAMIDE DURING CHRONIC ORAL DISOPYRAMIDE THERAPY [J].

AITIO, ML .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (04) :369-375

[2] THE EFFECT OF ENZYME-INDUCTION ON THE METABOLISM OF DISOPYRAMIDE IN MAN [J].

AITIO, ML ;

MANSURY, L ;

TALA, E ;

HAATAJA, M ;

AITIO, A .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (03) :279-285

[3] ENHANCED METABOLISM AND DIMINISHED EFFICACY OF DISOPYRAMIDE BY ENZYME-INDUCTION [J].

AITIO, ML ;

VUORENMAA, T .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 9 (02) :149-152

[4] INFLUENCE OF PH ON BUCCAL ABSORPTION AND RENAL EXCRETION OF DISOPYRAMIDE IN MAN [J].

ANKIER, SI ;

KAYE, CM .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (04) :672-673

[5]

ASHFORD JJ, 1979, BR J PHARM S, V66, P442

[6]

BAINES MW, 1976, J INT MED RES, V4, P5

[7] DISOPYRAMIDE SERUM AND PHARMACOLOGIC EFFECT KINETICS APPLIED TO ASSESSMENT OF BIOAVAILABILITY [J].

BRYSON, SM ;

WHITING, B ;

LAWRENCE, JR .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (05) :409-419

[8] RESOLUTION, ABSOLUTE-CONFIGURATION, AND ANTI-ARRHYTHMIC PROPERTIES OF THE ENANTIOMERS OF DISOPYRAMIDE, 4-(DIISOPROPYLAMINO)-2-(2-PYRIDYL)-2-PHENYLBUTYRAMIDE [J].

BURKE, TR ;

NELSON, WL ;

MANGION, M ;

HITE, GJ ;

MOKLER, CM ;

RUENITZ, PC .

JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (09) :1044-1048

[9]

COOK CS, 1982, DRUG METAB DISPOS, V10, P116

[10] QUANTITATIVE DETERMINATION OF QUINIDINE IN PLASMA [J].

CRAMER, G ;

ISAKSSON, B .

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1963, 15 (05) :553-&

← 1 2 3 4 5 6 7 8 →